文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

血清高密度脂蛋白水平及功能在钙化性主动脉瓣狭窄进展中的作用

Role of serum high density lipoprotein levels and functions in calcific aortic valve stenosis progression.

作者信息

Olgun Küçük Hilal, Küçük Uğur, Demirtaş Canan, Özdemir Murat

机构信息

Department of Cardiolgy, Siyami Ersek Thoracic and Cardiovascular Surgery Center Training and Research Hospital İstanbul 34668, Turkey.

Department of Cardiology, Gulhane Military Medical Academy Haydarpasa Training Hospital İstanbul 34668, Turkey.

出版信息

Int J Clin Exp Med. 2015 Dec 15;8(12):22543-9. eCollection 2015.


DOI:
PMID:26885240
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4730026/
Abstract

BACKGROUND: Clinical and epidemiological data well defines the role of atherosclerotic risk factors in pathogenesis of aortic stenosis. Especially dyslipidemia with elevated total and LDL cholesterol levels exerts certain histopathological changes on calcified valve tissue. Exact role of HDL in this process is not known. OBJECTIVE: To evaluate the lipid profiles of patients with mild aortic valve stenosis with special focus on HDL; HDL subspecies, serum apoA1 levels, HDL related PON1 and PAF-AH enzyme activities and to correlate this with disease progression rates. METHOD: 42 patients (26 female; 16 male), with calcific aortic valve stenosis were enrolled in the study. Serum fasting lipid parameters, HDL subspecies (HDL2, HDL3), serum apoA1 levels and HDL related PON1 and PAF-AH enzyme activities were determined. All participants underwent detailed follow-up transthoracic echocardiography examination. RESULTS: Among 42 study participants mean serum total cholesterol level was 195 ± 27.3 mg/dl, LDL-c level was 123 ± 19.1 mg/dl, HDL-c level was 44 ± 10.3 mg/dl and total cholesterol/HDL-c ratio was 4.64 ± 1.13. Basal peak aortic jet velocity (Vmax2) was 2.67 ± 0.39 m/sec, mean pressure gradient (Pmean2) was 15.6 ± 5.5 mmhg. Annual progression rate in peak aortic jet velocity (Vmax) was 0.23 ± 0.17 m/sec, in mean pressure gradient (Pmean) was 3 ± 2.1 mmhg. Annual progression rate in Pmean was most strongly correlated with serum HDL-c level and total/HDL-c ratio (r=-0.528 and 0.505; <0.001 and 0.001 respectively). Progression in Vmax values was positively correlated with serum LDL-c level and total/HDL-c ratio while negatively correlated with serum HDL-c levels (r=0.328, 0.499 and -0.464; P=0.034, 0.001 and 0.002 respectively). Among HDL subspecies HDL2 was the predominant type. HDL2 levels were found to be positively correlated with progression rates. There was no significant correlation between apolipoprotein A1 level and annual progression rate. Serum PON1 activity level was determined to be negatively correlated to doppler echocardiographic progression parameters while HDL related PAF-AH activity was independent of disease progression. CONCLUSION: Present study demonstrated a positive correlation between disease progression and serum total cholesterol/HDL-c ratio. Serum HDL-c level was inversely correlated with hemodynamic progression. The majority of HDL was HDL2 subtype. Among HDL related enzymes PON1 enzyme activity exhibited an inverse correlation with disease progression.

摘要

背景:临床和流行病学数据明确了动脉粥样硬化危险因素在主动脉瓣狭窄发病机制中的作用。尤其是总胆固醇和低密度脂蛋白胆固醇水平升高的血脂异常会对钙化瓣膜组织产生某些组织病理学变化。高密度脂蛋白在这一过程中的具体作用尚不清楚。 目的:评估轻度主动脉瓣狭窄患者的血脂谱,特别关注高密度脂蛋白;高密度脂蛋白亚类、血清载脂蛋白A1水平、与高密度脂蛋白相关的对氧磷酶1(PON1)和血小板活化因子乙酰水解酶(PAF-AH)的酶活性,并将其与疾病进展率相关联。 方法:42例钙化性主动脉瓣狭窄患者(26例女性;16例男性)纳入本研究。测定血清空腹血脂参数、高密度脂蛋白亚类(HDL2、HDL3)、血清载脂蛋白A1水平以及与高密度脂蛋白相关的PON1和PAF-AH酶活性。所有参与者均接受详细的经胸超声心动图随访检查。 结果:42例研究参与者中,血清总胆固醇水平平均为195±27.3mg/dl,低密度脂蛋白胆固醇水平为123±19.1mg/dl,高密度脂蛋白胆固醇水平为44±10.3mg/dl,总胆固醇/高密度脂蛋白胆固醇比值为4.64±1.13。基础主动脉峰值流速(Vmax2)为2.67±0.39m/秒,平均压力阶差(Pmean2)为15.6±5.5mmHg。主动脉峰值流速(Vmax)的年进展率为0.23±0.17m/秒,平均压力阶差(Pmean)的年进展率为3±2.1mmHg。Pmean的年进展率与血清高密度脂蛋白胆固醇水平和总胆固醇/高密度脂蛋白胆固醇比值相关性最强(r分别为-0.528和0.505;P均<0.001)。Vmax值的进展与血清低密度脂蛋白胆固醇水平和总胆固醇/高密度脂蛋白胆固醇比值呈正相关,而与血清高密度脂蛋白胆固醇水平呈负相关(r分别为0.328、0.499和-0.464;P分别为0.034、0.001和0.002)。在高密度脂蛋白亚类中,HDL2是主要类型。发现HDL2水平与进展率呈正相关。载脂蛋白A1水平与年进展率之间无显著相关性。血清PON1活性水平与多普勒超声心动图进展参数呈负相关,而与高密度脂蛋白相关的PAF-AH活性与疾病进展无关。 结论:本研究表明疾病进展与血清总胆固醇/高密度脂蛋白胆固醇比值呈正相关。血清高密度脂蛋白胆固醇水平与血流动力学进展呈负相关。大多数高密度脂蛋白为HDL2亚型。在与高密度脂蛋白相关的酶中,PON1酶活性与疾病进展呈负相关。

相似文献

[1]
Role of serum high density lipoprotein levels and functions in calcific aortic valve stenosis progression.

Int J Clin Exp Med. 2015-12-15

[2]
Alterations of paraoxonase and platelet-activating factor acetylhydrolase activities in patients on peritoneal dialysis.

Perit Dial Int. 2004

[3]
Paraoxonase 1 and platelet-activating factor acetylhydrolase activities in patients with low hdl-cholesterol levels with or without primary hypertriglyceridemia.

Arch Med Res. 2004

[4]
Impact of low-density lipoprotein cholesterol on progression of aortic valve sclerosis and stenosis.

Front Cardiovasc Med. 2023-7-17

[5]
Abnormalities in the relationship of paraoxonase 1 with HDL and apolipoprotein A1 and their possible connection to HDL dysfunctionality in type 2 diabetes.

Diabetes Res Clin Pract. 2018-4-5

[6]
Activation of paraoxonase 1 is associated with HDL remodeling ex vivo.

Clin Chim Acta. 2013-11-23

[7]
Association of cholesterol concentrations in low-density lipoprotein, high-density lipoprotein, and high-density lipoprotein subfractions, and of apolipoproteins AI and AII, with coronary stenosis and left ventricular function.

J Lab Clin Med. 1987-1

[8]
Lipid profile of patients with aortic stenosis might be predictive of rate of progression.

Am Heart J. 2004-5

[9]
Expression levels of paraoxonase-1 in aortic valve tissue are associated with the progression of calcific aortic valve stenosis.

J Thorac Dis. 2019-7

[10]
Thyroid substitution therapy induces high-density lipoprotein-associated platelet-activating factor-acetylhydrolase in patients with subclinical hypothyroidism: a potential antiatherogenic effect.

Thyroid. 2005-5

引用本文的文献

[1]
The Role of Paraoxonase-1 Activity, Apolipoprotein B Levels, and Apolipoprotein B/Apolipoprotein A-I Ratio as Risk Markers for Aortic Stenosis in Patients with a Bicuspid Aortic Valve.

Antioxidants (Basel). 2025-1-30

[2]
Molecular Features of Calcific Aortic Stenosis in Female and Male Patients.

CJC Open. 2024-6-11

[3]
Multimodal Analytical Tools to Enhance Mechanistic Understanding of Aortic Valve Calcification.

Am J Pathol. 2024-4

[4]
HDL-C Role in Acquired Aortic Valve Stenosis Patients and Its Relationship with Oxidative Stress.

Medicina (Kaunas). 2019-7-29

[5]
Degenerative Aortic Stenosis, Dyslipidemia and Possibilities of Medical Treatment.

Medicina (Kaunas). 2018-4-25

[6]
Risk factors for degenerative aortic valve disease in India: A case control study.

Med J Armed Forces India. 2018-1

本文引用的文献

[1]
Evaluation of links between high-density lipoprotein genetics, functionality, and aortic valve stenosis risk in humans.

Arterioscler Thromb Vasc Biol. 2013-12-12

[2]
Lipoprotein-associated phospholipase A2 is elevated in patients with severe aortic valve stenosis without clinically overt atherosclerosis.

Clin Chem Lab Med. 2012-10-1

[3]
Calcific aortic valve disease: not simply a degenerative process: A review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: Calcific aortic valve disease-2011 update.

Circulation. 2011-10-18

[4]
High-density lipoproteins (HDL) are present in stenotic aortic valves and may interfere with the mechanisms of valvular calcification.

Atherosclerosis. 2011-8-22

[5]
Evaluating the effectiveness of rosuvastatin in preventing the progression of diastolic dysfunction in aortic stenosis: A substudy of the aortic stenosis progression observation measuring effects of rosuvastatin (ASTRONOMER) study.

Cardiovasc Ultrasound. 2011-2-7

[6]
Prospective study of coronary heart disease vs. HDL2, HDL3, and other lipoproteins in Gofman's Livermore Cohort.

Atherosclerosis. 2010-10-23

[7]
Paraoxonase activity might be predictive of the severity of aortic valve stenosis.

J Heart Valve Dis. 2010-7

[8]
[Smoking, increase in plasma lipoprotein (a) and triglycerides, as well as decrease in plasma HDL-cholesterol concentrations seem to be linked with aortic valve stenosis and its progression].

Przegl Lek. 2009

[9]
Lowering plasma cholesterol levels halts progression of aortic valve disease in mice.

Circulation. 2009-5-26

[10]
Paraoxonases role in the prevention of cardiovascular diseases.

Biofactors. 2009

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索